Vaccines
Antigens Involved in Adaptive Immunity
Vaccinations
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 26, 2026

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
Bethany M Potter1,2, Anya F Weth1, Emma M Dangerfield1
1School of Chemical and Physical Sciences, Victoria University of Wellington, Wellington P.O. Box 600, New Zealand.
Covalently linking pathogen-associated molecular patterns (PAMPs) creates "chimeric" molecules that enhance immune cell activation and adjuvant activity. This strategy shows promise for infectious disease, allergy, and cancer immunotherapy vaccines.
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
06:57Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: